{"id":"W4385803938","doi":"10.1016/s0140-6736(23)01554-4","title":"Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet","topic":"Renal Diseases and Glomerulopathies","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Proteinuria; Clinical endpoint; Renal function; Internal medicine; Placebo; Nephropathy; Kidney disease; Clinical trial; Gastroenterology; Kidney; Pathology; Endocrinology; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003450224,0.000101612,0.0005495343,0.00007479071,0.00002656004,0.000005584135,0.00006308981,0.00003791593,0.000008562081],"category_scores_gemma":[0.0004418249,0.00005905159,0.0000568067,0.0002673474,0.00006404543,0.00004862666,0.00003081129,0.00009260686,0.000002708234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000173529,"about_ca_system_score_gemma":0.00005757547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001059393,"about_ca_topic_score_gemma":0.00000837392,"domain_scores_codex":[0.9989372,0.00008574861,0.0004020768,0.0001529261,0.0002704036,0.0001516064],"domain_scores_gemma":[0.9990793,0.0003035802,0.0001955781,0.0003018513,0.00006172161,0.0000579427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9822448,0.0004662499,0.01062883,0.0001235747,0.00007412562,0.000008072031,0.0006990433,0.00007032414,0.0006671064,0.00001876875,0.0005314833,0.004467599],"study_design_scores_gemma":[0.4806486,0.00078928,0.5176014,0.0002759186,0.00008981998,1.30758e-7,0.00003205628,0.0002346595,0.0001344391,0.00004579547,0.0001010669,0.00004681258],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973607,0.0001402178,0.000008148576,0.0002761633,0.00003262042,0.001247378,0.0007107721,0.00003096369,0.0001930455],"genre_scores_gemma":[0.9987485,0.0001962922,0.0001097518,0.0000794748,0.0001449933,0.0000170472,0.0006774483,0.00001176664,0.00001469042],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5069726,"threshold_uncertainty_score":0.2408054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01426850573932332,"score_gpt":0.2623249024482707,"score_spread":0.2480563967089474,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}